|

Ranquilon Clinical Trials

1 actively recruiting trial

Also known as: GB-115, N-(6-phenylhexanoyl)glycyl-L-tryptophan amide

Pipeline

Phase 4: 1

Top Sponsors

  • Valenta Pharm JSC1

Indications

  • Neurasthenia1
  • Adjustment Disorders1
  • Anxiety1

Other1 trial

Efficacy and Safety of Ranquilon in Patients With Anxiety Disorders Due to Neurasthenia and Adjustment Disorders
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.